Fas-670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia

Journal of Leukocyte Biology

Volumn 83, Issue 1, 2008, Pages 220-222

  Farre, L ^a   Bittencourt, A L ^b   Silva Santos, G ^a   Almeida, A ^a   Silva, A C ^a   Decanine, D ^a   Soares, G M ^a   Alcantara Jr , L C ^a   Van Dooren, S ^d   Galvao Castro B ^a   Vandamme, A M ^d   Van Weyenbergh, J ^a,c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Instituto de Investigação em Imunologia iii Millenium Institute   (Brazil)

^d REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Apoptosis; ATL; HTLV 1; STAT1; TNFRSF6

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; MESSENGER RNA; STAT1 PROTEIN;

ALLELE; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE PREDISPOSITION; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMOGENESIS; OUTCOME ASSESSMENT; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; T CELL LEUKEMIA;

ANTIGENS, CD95; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HTLV-I INFECTIONS; HUMANS; INTERFERON TYPE II; LEUKEMIA, T-CELL; LEUKOCYTES, MONONUCLEAR; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK FACTORS; RNA, MESSENGER; SURVIVAL RATE;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 38149127135     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0407198     Document Type: Article

References (16)

1. Tsukasaki, K., Miller, C. W., Kubota, T., Takeuchi, S., Fujimoto, T., Ikeda, S., Tomonaga, M., Koeffler, H. P. (2001) Tumor necrosis factor polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res. 61, 3770-3774.
2. Takeuchi, S., Matsushita, M., Tsukasaki, K., Takeuchi, N., Tomonaga, M., Komatsu, N., Ikezoe, T., Uehara, Y., Koeffler, H. P. (2005) P53 codon 72 polymorphism is associated with disease progression in adult T-cell leukemia/ lymphoma. Br. J. Haematol. 131, 552-553.
3. Muschen, M., Warskulat, U., Beckmann, M. W. (2000) Defining CD95 as a tumor suppressor gene. J. Mol. Med. 78, 312-325.
4. Sibley, K., Rollinson, S., Allan, J. M., Smith, A. G., Law, G. R., Roddam, P. L., Skibola, C. F., Smith, M. T., Morgan, G. J. (2003) Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res. 63, 4327-4330.
5. Ueda, M., Hung, Y. C., Terai, Y., Yamaguchi, H., Saito, J., Nunobiki, O., Noda, S., Ueki, M. (2005) Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesis. Gynecol. Oncol. 98, 129-133.
6. Tamiya, S., Etoh, K., Suzushima, H., Takatsuki, K., Matsuoka, M. (1998) Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. Blood 91, 3935-3942.
7. Debatin, K. M., Goldman, C. K., Waldmann, T. A., Krammer, P. H. (1993) Apo-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 81, 2972-2977.
8. Huang, Q. R., Morris, D., Manolios, N. (1997) Identification and characterization of polymorphisms in the promoter region of the human Apo-1/ Fas (CD95) gene. Mol. Immunol. 34, 577-582.
9. Shimoyama, M. (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br. J. Haematol. 79, 428-437.
10. Etoh, K., Tamiya, S., Yamaguchi, K., Okayama, A., Tsubouchi, H., Ideta, T., Mueller, N., Takatsuki, K., Matsuoka, M. (1997) Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res. 57, 4862-4867.
11. Takemoto, S., Matsuoka, M., Yamaguchi, K., Takatsuki, K. (1994) A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction. Blood 84, 3080-3085.
12. Kanemitsu, S., Ihara, K., Saifddin, A., Otsuka, T., Takeuchi, T., Nagayama, J., Kuwano, M., Hara, T. J. (2002) A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus. J. Rheumatol. 29, 1183-1188.
13. Nolsøe, R. L., Kelly, J. A., Pociot, F., Moser, K. L., Kristiansen, O. P., Mandrup-Poulsen, T., Harley, J. B. (2005) Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia. Genes Immun. 6, 699-706.
14. Sun, T., Zhou, Y., Li, H., Han, X., Shi, Y., Wang, L., Miao, X., Tan, W., Zhao, D., Zhang, X., Guo, Y., Lin, D. (2005) FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J. Exp. Med. 202, 967-974.
15. Taylor, G. P., Matsuoka, M. (2005) Natural history of adult T-cell leukemia/ lymphoma and approaches to therapy. Oncogene 24, 6047-6057.
16. Peter, M. E., Budd, R. C., Desbarats, J., Hedrick, S. M., Hueber, A. O., Newell, M. K., Owen, L. B., Pope, R. M., Tschopp, J., Wajant, H., Wallach, D., Wiltrout, R. H., Zörnig, M., Lynch, D. H. (2007) The CD95 receptor: apoptosis revisited. Cell 129, 447-450.